Label-free quantitative proteomic profiling reveals differential plasma protein expression in patients with obesity after treatment with liraglutide

Label-free quantitative proteomic profiling reveals differential plasma protein expression in patients with obesity after treatment with liraglutide

IntroductionTreatment and management of obesity is clinically challenging. The inclusion of GLP-1 receptor agonists (GLP1RA) in the medical management of obesity has proven to be efficacious. However, mechanisms underlying the molecular changes arising from GLP1RA treatment in patients with obesity...

Full description

Bibliographic Details
Main Authors: Afshan Masood, Hicham Benabdelkamel, Salini Scaria Joy, Abdulaziz Alhossan, Bashayr Alsuwayni, Ghalia Abdeen, Madhawi Aldhwayan, Nora A. Alfadda, Alexander Dimitri Miras, Assim A. Alfadda
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-09-01
Series:Frontiers in Molecular Biosciences
Subjects:
obesity
liraglutide
GLP1 receptor agonist
proteomics
label-free quantification
multimerin-2
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2024.1458675/full

Internet

https://www.frontiersin.org/articles/10.3389/fmolb.2024.1458675/full

Similar Items